Articles & Video
BioProcess International US 2021 Post Event Report
We revisit the highlights of the first hybrid BioProcess International conference and exhibition.
BioProcess International | BioProcess Insider
BioProcess International is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics.
Allogeneic and Autologous Cell Therapies Survey 2021
What pitfalls come with each product type in cell therapy manufacturing and how can they be alleviated? We want to hear from you!
Tackling supply shortages impacting biopharma | Spectrum Chemical
Russell Kneipp, COO at Spectrum Chemical Manufacturing Corporation, discusses how the company is helping alleviate the disruption of supply shortages impacting biopharma during COVID-19.
Cell culture media optimization - Interview with Tim Mullane, President and COO, FUJIFILM Irvine Scientific
In this exclusive interview for BWB TV, Tim Mullane, President and COO of FUJIFILM Irvine Scientific, discusses how the company serves the biotech industry, how it has evolved since the acquisition by FUJIFILM and the impacts of COVID-19.
Commercialization of Cell & Gene Therapies
This ebook presents insights from industry leaders, including partnering strategies, process technologies and control considerations.
Novel and Difficult Targets in Antibody Drug Discovery
We explore leading strategies in handling novel and difficult targets in therapeutic antibody discovery.
Challenge to Peptide Manufacturing Technologies
We introduce the benefits of (i) Microwave synthesis and (ii) STag synthesis (tag-assisted LPPS) with some summary data, and discuss our manufacturing strategy depending on the production scale and the stages of development.
Life Sciences Survey: COVID-19 Impacts One Year On
Take part in our industry survey on the impacts of COVID-19 on the life sciences one year on to get exclusive early access to the final report.
63% of cell and gene therapy professionals changed their supply chain strategies due to COVID-19
We examine new data on the challenges in cell and gene therapy supply chain and manufacturing as a result of the COVID-19 pandemic.
Human Monoclonal Antibodies for SARS-CoV-2
We look at single cell technologies for the isolation of human monoclonals, the molecular basis for SARS-CoV-2 neutralization and antibody synergistic exploration.
REPORT: Diversity, Equity and Inclusion in the Life Sciences 2021
Explore the Diversity, Equity and Inclusion in the Life Sciences 2021 report based on an exclusive study of 483 industry professionals.
REPORT: COVID-19 Response in Cell & Gene Therapy Manufacturing 2021
This exclusive report uncovers the major changes in the cell and gene therapy sector during the COVID-19 pandemic.
Developments in ADC Technology: Toxicity and Design Strategies
We examine the latest developments in ADC technology, as discussed by industry leaders at the Antibody Engineering & Therapeutics conference.
Survey: Antibody Engineering & Therapeutics State of the Industry 2021
What has changed in antibody engineering and antibody-based therapeutics over the last year? Tell us your experience in our industry survey.
Report: Oligonucleotide, Peptide, mRNA and Genome Edited Therapeutics State of the Industry 2021
How has the oligonucleotide, peptide, mRNA and genome editing sector transformed over the last year? This industry report provides insight.
eBook: Antibody Discovery, Selection & Screening
This ebook uncovers the latest approaches and emerging tools for therapeutic antibody discovery.
A look back at TIDES Asia Virtual Scientific Forum 2021
We explore the best of on-demand webinars from this year's TIDES Asia Virtual Scientific Forum.
Scaling up manufacturing when it’s needed most
Learn how Thermo Fisher Scientific scaled up raw material manufacturing for mRNA production, leaning on decades of experience.
Survey: Cell & Gene Therapy COVID-19 Response
What changes are happening in the cell and gene therapy sector as a result of the pandemic? Tell us your experience.